Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021

Urging all Shareholders to Vote For Proposals Related to Merger with ReShape LifeSciences Inc.

Meeting to be held via Webcast at 8:30 a.m. Pacific

SAN DIEGO, CA / ACCESSWIRE / May 18, 2021 / Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, announced that the special shareholders meeting for Obalon Stockholders (the “Special Meeting”) on May 13, 2021 was convened without a quorum and adjourned until Tuesday, May 25, 2021 at 8:30 a.m. PT to allow more time for stockholders to vote.

Regardless of the number of shares owned, all stockholders are encouraged to have their voices heard in relation to this imperative matter concerning their vested interests by voting prior to the Special Meeting. To achieve a quorum for the Special Meeting, a majority of voting power of the shares of Company stock entitled to vote must be present or represented by proxy.

Obalon stockholders as of the close of business on April 7, 2021, the record date for the special meeting, are eligible to vote and attend the virtual special meeting even if they do not currently hold those shares. The Obalon board of directors has recommended that the Obalon stockholders vote FOR each of the proposals.

All materials regarding the Obalon special meeting are available at www.virtualshareholdermeeting.com/OBLN2021SM.

Remember, Your Vote Is Important, No Matter How Many or How Few Shares You Own 


Obalon urges all stockholders of record who have not yet voted to do so by following the instructions on their proxy card to vote by phone or online.

If you have questions or require assistance in voting your proxy, please call our proxy solicitor MacKenzie Partners toll-free at (800) 322-2885 or by email at proxy@mackenziepartners.com for assistance.

About Obalon Therapeutics, Inc. 

Obalon Therapeutics, Inc. (NASDAQ: OBLN) is a San Diego-based company focused on developing and commercializing novel technologies for weight loss.

Important Additional Information and Where to Find It

This communication is being made in respect of the proposed merger involving Obalon Therapeutics, Inc. and ReShape Lifesciences Inc. Obalon filed a registration statement on Form S-4 (File No. 333-254841) with the SEC. The Registration Statement on Form S-4 was declared effective on April 13, 2021. The final joint proxy and consent solicitation statement/prospectus was filed with the SEC on April 13, 2021 and was first sent to the stockholders of Obalon and ReShape on or about April 13, 2021. The final joint proxy and consent solicitation statement/prospectus contains important information about Obalon, ReShape, the proposed merger and related matters. STOCKHOLDERS ARE URGED TO READ THE FINAL JOINT PROXY STATEMENT/PROSPECTUS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS) AND OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY IN THEIR ENTIRETY, AS THEY CONTAIN IMPORTANT INFORMATION THAT STOCKHOLDERS SHOULD CONSIDER BEFORE MAKING A DECISION ABOUT THE MERGER AND RELATED MATTERS. In addition to receiving the final joint proxy statement/prospectus and proxy card or voting instruction form by mail, stockholders will also be able to obtain the final joint proxy statement/prospectus, as well as other filings containing information about Obalon, without charge, from the SEC’s website (http://www.sec.gov) or, without charge, by directing a written request to: Obalon Therapeutics, Inc., 5421 Avenida Encinas, Suite F, Carlsbad, CA 92008, Attention: Corporate Secretary.

Previous Article

Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021

Next Article

Bombardier Collaborates with Sterling for Enhanced Worldwide Customer Support of Parts Shipments

Related Posts

‫ LONGi تصدر تقريرها السنوي لعامي 2021 والربع الأول من عام 2022

شيان، الصين, 9 مايو 2022/PRNewswire/ — أصدرت LONGi تقريرها السنوي لعامي 2021 والربع الأول من عام 2022 للمساهمين العالميين، كاشفة عن أن الشركة حافظت على عمليات مستقرة وحققت شحنات عالمية كبيرة من المنتجات طوال هذه الفترة.  وقدر التقرير الإيرادات التشغيلية لشركة LONGi لعام 2021 ب 80.932 مليار يوان صيني، بزيادة سنوية قدرها 48.27%. وبلغ صافي […]

كوريا تُروج للجينسنغ الأحمر في الشرق الأوسط

يكمل مركز ايه تي بنجاح ندوة الجينسنغ الكوري في دولة الإمارات العربية المتحدة بمراجعات إيجابية يتم تقديم الفوائد الطبية للجينسنغ الأحمر، بما في ذلك تعزيز المناعة وتخفيف التعب والسلامة دبي، الإمارات العربية المتحدة وسيول، كوريا الجنوبية, 24 نوفمبر / تشرين ثاني 2022/PRNewswire/ — عقدت وزارة الزراعة والأغذية والشؤون الريفية الكورية والمؤسسة الكورية للصيد الزراعي وتجارة […]

‫أول وجهة عبر الإنترنت في الشرق الأوسط للجمال الفاخر النظيف والأخلاقي تحتضن هويتها الجديدة

دبي، الإمارات العربية المتحدة،, 26 سبتمبر 2022 /PRNewswire/ — Balmessence ، الوجهة الأولى والوحيدة عبر الإنترنت في الشرق الأوسط للجمال الفاخر النظيف والأخلاقي، يعاد إطلاقها باسم  ELUXURA وتنتقل إلى منزلها الجديد على الإنترنت على eluxura.com . منذ بدء البث المباشر في عام 2016، دعت شركة Balmessence ، التي أصبحت الآن ELUXURA ، إلى التحول والشفافية في سوق التجميل، مما ألهم المستهلكين لاتخاذ خيارات مستدامة وأخلاقية. تقول أنجيلا […]

German Consul General in Dubai congratulates door2door and Swvl on their merger as an important sign for future relationship between United Arab Emirates and Germany

Excellent timing for both companies: UAE and Germany celebrate their 50th anniversary of political relations this year Swvl & door2door welcome German Consul General in Dubai discussing how to further strengthen relationships between UAE and Germany This week’s acquisition of Volt Lines in Turkey marks another milestone in the company’s expansion strategy DUBAI, UAE, May […]